✦ LIBER ✦

Viral vector-mediated gene therapy for Parkinson's disease

✍ Scribed by Marina E. Emborg; Nicole Deglon; Liza Leventhal; Patrick Aebischer; Jeffrey H. Kordower

Book ID: 118629671
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 690 KB
Volume: 1
Category: Article
ISSN: 1566-2772
DOI: 10.1016/s1566-2772(01)00027-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Viral vectors, animal models and new the

Viral vectors, animal models and new therapies for Parkinson's disease

✍ Bernard Schneider; Romain Zufferey; Patrick Aebischer 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Recombinant adeno-associated viral vecto

Recombinant adeno-associated viral vectors bring gene therapy for Parkinson's disease closer to reality

✍ Shin-ichi Muramatsu; Lijun Wang; Kunihiko Ikeguchi; Ken-ichi Fujimoto; Imaharu N 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 390 KB

Gene therapy for Parkinson's disease

✍ Anders Björklund 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Gene therapy for Parkinson's disease

✍ Kathryn Senior 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Gene therapy for Parkinson's disease

✍ Tomas Bjorklund; Jeffrey H. Kordower 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract The once fantastic theoretical concept that patients with Parkinson's disease (PD) would receive gene therapy in an attempt to alleviate their symptoms and potentially modify the course of their disease has become a reality. On the basis of positive preclinical data, four different gene

Parkinson's Disease Volume 1052 || Viral

Parkinson's Disease Volume 1052 || Viral Vectors

✍ Schneider, Bernard L. 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 34 KB

Parkinson’s disease is the second most prevalent neurodegenerative disease and is characterized by the irreversible loss of dopamine neurons. Despite its high prevalence in society and many decades of research, the origin of the pathogenesis and the molecular determinants involved in the disorder ha